CN Patent

CN106749242B — 阿维巴坦中间体的制备方法

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2021-04-02 · 5y expired

What this patent protects

本发明涉及阿维巴坦中间体的制备方法，该中间体为(1R,2S,5R)‑6‑苄氧基‑7‑氧代‑1,6‑二氮杂环[3.2.1]辛烷‑2‑甲酰胺。该方法容易实施，总收率高，得到的产品纯度高，易纯化。

USPTO Abstract

本发明涉及阿维巴坦中间体的制备方法，该中间体为(1R,2S,5R)‑6‑苄氧基‑7‑氧代‑1,6‑二氮杂环[3.2.1]辛烷‑2‑甲酰胺。该方法容易实施，总收率高，得到的产品纯度高，易纯化。

Drugs covered by this patent

Patent Metadata

Patent number: CN106749242B
Jurisdiction: CN
Classification: —
Expires: 2021-04-02
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Institute of Pharmaceutical Industry
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.